David Rigal

Title: David Rigal - Innovator in Pharmaceutical Compositions

Introduction

David Rigal is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on compositions that include venglustat. His expertise and dedication to advancing medical treatments have earned him recognition in the industry.

Latest Patents

David Rigal holds 1 patent related to pharmaceutical compositions comprising venglustat. This patent details the formulation of pharmaceutical compositions, including dosage forms such as tablets or capsules. The compositions consist of venglustat in its free base or pharmaceutically acceptable salt form, along with a diluent or filler and a lubricant. The patent also discusses processes for manufacturing these compositions and methods for their use in treating or preventing diseases.

Career Highlights

David Rigal is currently associated with Genzyme Corporation, a leading biotechnology company known for its focus on rare diseases and innovative therapies. His work at Genzyme has allowed him to contribute to the development of groundbreaking pharmaceutical solutions.

Collaborations

David collaborates with talented professionals in his field, including Audrey Jeanjean and Danielle Combessis. Their combined expertise fosters a productive environment for innovation and research.

Conclusion

David Rigal's contributions to pharmaceutical compositions demonstrate his commitment to improving healthcare through innovation. His work continues to impact the industry positively, paving the way for new treatment options.